Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease

Summary

The clinical study with UMC119-06 is designed to investigate the safety in patients with Chronic Obstructive Pulmonary Disease. This will be a dose escalation, open label, single-center study in adult with chronic obstructive pulmonary disease. UMC119-06 is ex vivo cultured human umbilical cord tissue-derived mesenchymal stem cells product which is intended for treatment of chronic obstructive pulmonary disease.

Timeline

Start

2020-06-11

Primary completion

2023-12-31

Completion

2024-06-30

Drugs

Indications